, and South Korea. We are an agile, committed, and innovative global specialty pharma business and a preferred partner... for innovator pharma companies, instigating a paradigm shift in the life cycle management of iconic medicines. We seek...
We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, national origin, disability status, protected veteran status, or any other characteri...
in the movement (via air, road, sea or courier – export & import) of pharma product & other goods required within the... procedures and documentation. Adhere to the Duty & VAT payment policy. Complete Import declarations for pharma related goods...
Opportunity: They are looking for a Healthcare/Pharma Associate Director to help grow and generate new business within this team... pharma clients. You will be involved in areas of business development directing and winning proposals and working closely...
Crude prices came under pressure after US data pointed to persistent labour market strength which further dimmed prospects of an early decline in US interest rates. Continue Reading »
Freshworks now expects annual revenue between $695 million and $705 million, compared with its previous forecast of $703.5 million to $711.5 million. Continue Reading »
While gold is traditionally considered a hedge against inflation, high interest rates kept by the US Fed to tame the rising prices can increase the opportunity cost of holding the non-yielding bullion. Continue Reading »
Manpansand Beverages' top officials have been asked to pay penalties totaling ₹74 lakh by SEBI for violations including misstating and manipulating financial statements. Continue Reading »
Stock Market Today- Cipla, Aurobindo, Torrent are 3 preferred picks of HSBC Research on healthy Q4 expectations. HSBC expects 38.4% y-o-y rise in net profit of pharma companies in their coverage during Q4 helped by rising US sales compensating for slower growth in India Continue Reading »
SK Finance's proposed IPO is a combination of a fresh issue of equity shares worth ₹500 crore and an OFS of up to ₹1,700 crore by promoters and investor shareholders Continue Reading »
Emudhra, a leading certifying authority in India, has seen its stock value surge by 245% in the past year, reaching ₹738.40. Centrum Broking in its recent note revised its price target price on the stock to ₹832 apiece. Reflecting on a strong spike in the share price, it adjusted its rating. Continue Reading »
Post FY24 results, most brokerage houses have kept their target price for Tata Chemicals at least 10% lower than the current market price Continue Reading »